Erratum: Arming an oncolytic herpes simplex virus type 1 with a single-chain fragment variable antibody against PD-1 for experimental glioblastoma therapy (Clinical Cancer Research (2019) 25 (290–299) DOI: 10.1158/1078-0432.CCR-18-2311)

  • Carmela Passaro
  • , Quazim Alayo
  • , Isabel DeLaura
  • , John McNulty
  • , Korneel Grauwet
  • , Hirotaka Ito
  • , Vivek Bhaskaran
  • , Marco Mineo
  • , Sean E. Lawler
  • , Khalid Shah
  • , Maria C. Speranza
  • , William Goins
  • , Eric McLaughlin
  • , Soledad Fernandez
  • , David A. Reardon
  • , Gordon J. Freeman
  • , E. Antonio Chiocca
  • , Hiroshi Nakashima

Research output: Contribution to journalComment/debate

5 Scopus citations

Abstract

In the original version of this article (1), the name of the third author, Isabel DeLaura, is incorrect. The name has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Original languageEnglish
Pages (from-to)758
Number of pages1
JournalClinical Cancer Research
Volume26
Issue number3
DOIs
StatePublished - Feb 1 2020

Fingerprint

Dive into the research topics of 'Erratum: Arming an oncolytic herpes simplex virus type 1 with a single-chain fragment variable antibody against PD-1 for experimental glioblastoma therapy (Clinical Cancer Research (2019) 25 (290–299) DOI: 10.1158/1078-0432.CCR-18-2311)'. Together they form a unique fingerprint.

Cite this